Healthcare Services

Global Mitral Valve Disease Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Mitral Valve Disease Market From 2026 To 2030?

The mitral valve disease market size has observed substantial growth in recent years. It is anticipated to expand from $3.28 billion in 2025 to $3.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.7%. The expansion witnessed in the past can be ascribed to an escalating prevalence of heart valve disorders, an increased dependence on echocardiography diagnostics, a surge in surgical mitral valve repair procedures, the implementation of anticoagulation therapies, and improvements in hospital cardiac care infrastructure.

The mitral valve disease market is anticipated to show substantial expansion in the coming years. It is projected to achieve a size of $5.01 billion in 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This expected increase throughout the forecast period can be attributed to the rise in minimally invasive mitral valve procedures, an escalating demand for TMVR solutions, broader adoption of remote cardiac monitoring, increased capital allocated to valve repair devices, and the advancement of tailored therapeutic approaches. Significant trends during the forecast period encompass breakthroughs in precision medicine-based mitral valve treatments, the integration of artificial intelligence in mitral valve diagnostics and surveillance, the proliferation of cloud-based cardiac imaging and data platforms, the utilization of IoT-enabled remote cardiac monitoring devices, and a heightened implementation of robotic-assisted mitral valve repair systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

What Major Drivers Are Influencing Demand In The Mitral Valve Disease Market?

The expanding occurrence of vascular heart diseases is anticipated to drive the advancement of the mitral valve disease market in the future. These conditions refer to a collection of ailments that impact the blood vessels feeding the heart or located within the heart’s structure. The rise in vascular heart disease cases stems from an intricate combination of lifestyle decisions, shifts in demographics, various medical conditions, environmental influences, and genetic elements. Specific vascular heart diseases, such as ischemic heart disease and hypertension, can indirectly contribute to mitral valve disease by impairing the heart’s overall structure and functional capabilities, thereby resulting in conditions that impact the mitral valve. For instance, in November 2024, according to the Scottish Government, a Scotland-based government agency, the prevalence of any cardiovascular disease among adults significantly increases with age, reaching 42% for individuals aged 75 and over. Consequently, the rising occurrence of vascular heart diseases is fueling the growth of the mitral valve disease market.

Which Segments Are Included In The Analysis Of The Mitral Valve Disease Market?

The mitral valve disease market covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)

3) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

Which Upcoming Trends Are Expected To Influence The Mitral Valve Disease Market?

Leading companies within the mitral valve disease market are engaged in the development of stented tissue valves, responding to the escalating demand for minimally invasive treatment options. These stented tissue valves are engineered to offer durable and reliable performance, providing patients with an alternative to conventional surgical interventions. For example, in April 2024, Medtronic, an Ireland-based healthcare company, unveiled the Avalus Ultra valve, an advanced surgical aortic tissue valve created for improved ease of use during implantation and for long-term patient management. Drawing upon a decade of clinical experience with the original Avalus valve, the Avalus Ultra incorporates a low valve profile for simpler implantation, a PEEK base frame to ensure consistent circularity, and an industry-leading Effective Orifice Area (EOA) that can promote greater blood flow. Additionally, it features a radiopaque coil for clear visibility during subsequent valve-in-valve procedures.

Which Key Industry Participants Are Active In The Mitral Valve Disease Market?

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Read the full mitral valve disease market report here:

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Mitral Valve Disease Market?

Europe was the largest region in the mitral valve disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Mitral Valve Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp

Browse Through More Reports Similar to the Global Mitral Valve Disease Market 2026, By The Business Research Company

Next Generation Antibody Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

Mammalian Polyclonal Immunoglobulin G Igg Antibody Global Market Report

https://www.thebusinessresearchcompany.com/report/mammalian-polyclonal-immunoglobulin-g-igg-antibody-global-market-report

Recombinant Proteins Global Market Report

https://www.thebusinessresearchcompany.com/report/recombinant-proteins-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795